🎉 M&A multiples are live!
Check it out!

Akums Valuation Multiples

Discover revenue and EBITDA valuation multiples for Akums and similar public comparables like Suven Pharma, Dishman Carbogen Amics, and Jubilant Pharmova.

Akums Overview

About Akums

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).


Founded

2004

HQ

India
Employees

16.1K+

Website

akums.in

Financials

LTM Revenue $476M

LTM EBITDA $57.7M

EV

$738M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Akums Financials

Akums has a last 12-month revenue of $476M and a last 12-month EBITDA of $57.7M.

In the most recent fiscal year, Akums achieved revenue of $467M and an EBITDA of $15.2M.

Akums expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Akums valuation multiples based on analyst estimates

Akums P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $404M $467M XXX XXX XXX
Gross Profit $147M $136M XXX XXX XXX
Gross Margin 37% 29% XXX XXX XXX
EBITDA $35.9M $15.2M XXX XXX XXX
EBITDA Margin 9% 3% XXX XXX XXX
Net Profit -$29.1M $11.0M XXX XXX XXX
Net Margin -7% 2% XXX XXX XXX
Net Debt $35.2M $56.4M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Akums Stock Performance

As of April 15, 2025, Akums's stock price is INR 434 (or $5).

Akums has current market cap of INR 66.5B (or $772M), and EV of INR 63.5B (or $738M).

See Akums trading valuation data

Akums Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$738M $772M XXX XXX XXX XXX $0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Akums Valuation Multiples

As of April 15, 2025, Akums has market cap of $772M and EV of $738M.

Akums's trades at 1.6x LTM EV/Revenue multiple, and 12.8x LTM EBITDA.

Analysts estimate Akums's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Akums and 10K+ public comps

Akums Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $738M XXX XXX XXX
EV/Revenue 1.6x XXX XXX XXX
EV/EBITDA 15.8x XXX XXX XXX
P/E 33.3x XXX XXX XXX
P/E/Growth 0.8x XXX XXX XXX
EV/FCF 37.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Akums Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Akums Valuation Multiples

Akums's NTM/LTM revenue growth is 11%

Akums's revenue per employee for the last fiscal year averaged $29K, while opex per employee averaged $8K for the same period.

Over next 12 months, Akums's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Akums's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Akums and other 10K+ public comps

Akums Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 16% XXX XXX XXX XXX
EBITDA Margin 10% XXX XXX XXX XXX
EBITDA Growth -58% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 21% XXX XXX XXX XXX
Revenue per Employee $29K XXX XXX XXX XXX
Opex per Employee $8K XXX XXX XXX XXX
S&M Expenses to Revenue 1% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 27% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Akums Public Comps

See public comps and valuation multiples for Contract Research & Manufacturing and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
Suven Pharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Akums M&A and Investment Activity

Akums acquired  XXX companies to date.

Last acquisition by Akums was  XXXXXXXX, XXXXX XXXXX XXXXXX . Akums acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Akums

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Akums

When was Akums founded? Akums was founded in 2004.
Where is Akums headquartered? Akums is headquartered in India.
How many employees does Akums have? As of today, Akums has 16.1K+ employees.
Is Akums publicy listed? Yes, Akums is a public company listed on BOM.
What is the stock symbol of Akums? Akums trades under 544222 ticker.
When did Akums go public? Akums went public in 2024.
Who are competitors of Akums? Similar companies to Akums include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of Akums? Akums's current market cap is $772M
What is the current revenue of Akums? Akums's last 12-month revenue is $476M.
What is the current EBITDA of Akums? Akums's last 12-month EBITDA is $57.7M.
What is the current EV/Revenue multiple of Akums? Current revenue multiple of Akums is 1.6x.
What is the current EV/EBITDA multiple of Akums? Current EBITDA multiple of Akums is 12.8x.
What is the current revenue growth of Akums? Akums revenue growth between 2023 and 2024 was 16%.
Is Akums profitable? Yes, Akums is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.